John Lowe

John Lowe

Medchem Advisor

John A. Lowe III is a medicinal chemist with 30 years of experience in drug discovery and development at Pfizer, Inc. He co-discovered the first nonpeptide Substance P (NK1) receptor antagonist, and the novel, atypical antipsychotic drug, ziprasidone. Since 2009, he consults for the biotech and pharmaceutical industry on drug design and conducts third-party due diligence evaluation.


Fill in the form and will be in touch with you shortly.

Google reCaptcha: Invalid site key.

Why a form?
Your message is important to us so thank you for filling in our form – it will be received by the intended recipient and you will receive a reply via email. We’ve introduced a form to better protect our team from website scraping generated spam but hope that real people with real messages will still take the time to complete it.